We are live on ! Find out more
PEPL

PepperLime Health Acquisition Corporation Class A Ordinary Share

Delisted

PEPL was delisted on the 21st of March, 2024.

43 hedge funds and large institutions have $172M invested in PepperLime Health Acquisition Corporation Class A Ordinary Share in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $152M → $172M (+$20.1M)

0% more funds holding

Funds holding: 4343 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
43
Holders Change
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
6
Reduced
10
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Prelude Capital Management
New York
$1.59M
Citigroup
27
Citigroup
New York
$1.28M
AC
28
Aristeia Capital
Connecticut
$1.27M +$1.26M +124,625 New
MTCM
29
Mint Tower Capital Management
Netherlands
$766K
Geode Capital Management
30
Geode Capital Management
Massachusetts
$598K +$102K +10,096 +21%
WAM
31
Weiss Asset Management
Massachusetts
$421K
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$377K -$45.1K -4,466 -11%
WAM
33
Wolverine Asset Management
Illinois
$374K -$64K -6,348 -15%
JP Morgan Chase
34
JP Morgan Chase
New York
$184K -$165K -16,310 -48%
LCM
35
Landscape Capital Management
New Jersey
$147K +$145K +14,382 New
WAM
36
Warberg Asset Management
Illinois
$144K
AC
37
Ayrton Capital
Connecticut
$133K
WC
38
Wealthspring Capital
New York
$133K -$84.5K -8,380 -39%
RCM
39
Robinson Capital Management
Michigan
$54.4K
CM
40
Cohanzick Management
New York
$25.4K -$1.18K -117 -4%
UBS Group
41
UBS Group
Switzerland
$12.2K
EC
42
Elequin Capital
New York
$4.69K -$101 -10 -2%
Barclays
43
Barclays
United Kingdom
$4.17K
KIM
44
Karpus Investment Management
New York
-$4.15M -415,750 Closed
UOC
45
UBS O'Connor
Illinois
-$2.38M -238,623 Closed
WRBC
46
W.R. Berkley Corp
Connecticut
-$1.73M -173,094 Closed
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
-$378 -37,863 Closed
Parallax Volatility Advisers
48
Parallax Volatility Advisers
California
-$194K -19,395 Closed
CH
49
CVI Holdings
Delaware
-$138K -13,831 Closed
SMA
50
Sage Mountain Advisors
Georgia
-$120K -12,000 Closed

PEPL Hedge Fund Activity: Q4 2022 in Review

43 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) for Q4 2022, worth a combined $172M — up 13% from $152M a quarter earlier.

Fund positioning in PEPL was balanced in Q4 2022: 7 funds opened new positions, 7 closed out, 6 added to existing stakes and 10 trimmed.

The largest buyer was Sandia Investment Management, opening a new position worth an estimated $9.61M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $4.15M sold.

  • 43 institutional investors held PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $172M of PepperLime Health Acquisition Corporation Class A Ordinary Share stock for Q4 2022, up 13% quarter-over-quarter.
  • 7 funds opened new PepperLime Health Acquisition Corporation Class A Ordinary Share positions in Q4 2022 and 7 closed out, a net change of 0 holders.
  • The largest PepperLime Health Acquisition Corporation Class A Ordinary Share buyer in Q4 2022 was Sandia Investment Management, an estimated $9.61M added.
  • The largest PepperLime Health Acquisition Corporation Class A Ordinary Share seller in Q4 2022 was Karpus Investment Management, an estimated $4.15M sold.

Based on aggregated 13F filings for Q4 2022.